Stock Scorer

20/20 Biolabs, Inc. (AIDX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 250K 500K 750K Q1 '25: 553.8K Q2 '25: 535.1K Q1 '26: 353.4K Q2 '26: 730.6K Q1 '25 Q2 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 150K 300K 450K Q1 '25: 165.8K Q2 '25: 163.3K Q1 '26: 62.9K Q2 '26: 304.7K Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q1 '25: -772.2K Q2 '25: -845.7K Q1 '26: -1.4M Q2 '26: -1.2M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Net Income Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q1 '25: -764.6K Q2 '25: -840.9K Q1 '26: -2.2M Q2 '26: -1.5M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q1 '25: 388K Q2 '25: 371.8K Q1 '26: 290.5K Q2 '26: 425.8K Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q1 '25: -488.3K Q2 '25: -534.1K Q1 '26: -1.3M Q2 '26: -605.5K Q1 '25 Q2 '25 Q1 '26 Q2 '26

Shares Outstanding Quarterly

0 4M 8M 12M Q1 '25: 4.8M Q2 '25: 4.8M Q1 '26: 7.7M Q2 '26: 10.8M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

-1.20 -0.80 -0.40 0.00 0.40 0.80 1.20 FY24: -1.16 FY25: -0.76 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for AIDX: Free Cash Flow. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.